[{"Assets_0_Q3_USD":233051000.0,"CommonStockSharesOutstanding_0_Q3_shares":36992122.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-73105000.0,"NetIncomeLoss_1_Q3_USD":-32834000.0,"NetIncomeLoss_3_Q3_USD":-101952000.0,"StockholdersEquity_0_Q3_USD":182098000.0,"Ticker":"RVNC","CIK":"1479290","name":"REVANCE THERAPEUTICS, INC.","OfficialName":"Revance Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1265045755.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181102"}]